BURWIG SUSAN E 4

What Happened
Susan E. Burwig, Executive Vice President, Operations at Medpace Holdings, was granted two derivative awards on 2026-04-24: 10,000 option-like awards (reported at $0.00) and 5,000 restricted stock units (RSUs) (reported at $0.00), for a total of 15,000 awards. The filing reports $0 cash paid because these are compensation awards, not open-market purchases or sales.

Key Details

• Transaction date: 2026-04-24; Form 4 filed 2026-04-28 (filed within typical two-business-day window).
• Grants reported: 10,000 derivative award units @ $0.00 (F1); 5,000 RSUs @ $0.00 (F2/F3). Total granted = 15,000.
• Amount/Value on grant: $0 reported (common for awards/grants on Form 4).
• Shares owned after transaction: Not specified in the provided filing details.
• Notable footnotes:
  • F1: The 10,000 option-like award vests on the second anniversary of the grant, subject to continued employment.
  • F2/F3: Each RSU represents a contingent right to one share; the 5,000 RSUs vest in full on the second anniversary, subject to continued employment.
• No 10b5-1 plan, tax-withholding sale, or immediate sale/exercise was indicated in the provided information.

Context
These grants are standard equity compensation: RSUs convert to shares upon vesting, and the option-like awards vest after two years and would require exercise to convert into shares. Because this is a compensation grant (not a purchase or sale), it is not a direct market buy/sell signal; investors typically view such awards as part of routine executive compensation and incentive alignment rather than an immediate insider bet.